Heart attack patients who received newer-generation drug-eluting stents were at lower risk of cardiac death and cardiac events than patients on bare metal stents, according to a study in the Journal of the American Medical Association. Researchers followed 1,200 patients after ST-segment elevation myocardial infarction. Patients who received bare metal stents also had experienced more clotting a year after the procedure than those who received new drug-emitting stents. HealthDay News (8/21)
Drug-releasing stents linked to lower risk of cardiac events
August 23, 2012 By
